Douglas Bryant - Quidel CEO and President and Director

QDEL Stock  USD 39.68  0.87  2.15%   

CEO

Mr. Douglas C. Bryant serves as President, Chief Executive Officer, Director of Company. Prior to joining us, Mr. Bryant served as Executive Vice President and Chief Operating Officer at Luminex Corporationrationration, managing its Bioscience Group, Luminex Molecular Diagnostics, manufacturing, RD, technical operations and commercial operations. From 1983 to 2007, Mr. Bryant held various worldwide commercial operations positions with Abbott Laboratories including, among others Vice President of Abbott Vascular for AsiaJapan, Vice President of Abbott Molecular Global Commercial Operations and Vice President of Abbott Diagnostics Global Commercial Operations. Earlier in his career with Abbott, Mr. Bryant was Vice President of Diagnostic Operations in Europe, the Middle East and Africa and Vice President of Diagnostic Operations in Asia Pacific. Mr. Bryant has over 30 years of industry experience in sales and marketing, product development, manufacturing and service and support in both the diagnostics and life sciences markets since 2009.
Age 66
Tenure 15 years
Address 9975 Summers Ridge Road, San Diego, CA, United States, 92121
Phone858 552 1100
Webhttps://www.quidelortho.com
Bryant holds a B.A. in Economics from the University of California at Davis.

Quidel Management Efficiency

The company has return on total asset (ROA) of 0.0201 % which means that it generated a profit of $0.0201 on every $100 spent on assets. This is way below average. Quidel's management efficiency ratios could be used to measure how well Quidel manages its routine affairs as well as how well it operates its assets and liabilities. Return On Capital Employed is expected to rise to 0.03 this year, although the value of Return On Tangible Assets will most likely fall to (0). At this time, Quidel's Intangible Assets are quite stable compared to the past year. Other Assets is expected to rise to about 477.9 M this year, although the value of Deferred Long Term Asset Charges will most likely fall to about 25.7 M.
The company currently holds 2.61 B in liabilities with Debt to Equity (D/E) ratio of 0.6, which is about average as compared to similar companies. Quidel has a current ratio of 1.63, which is within standard range for the sector. Debt can assist Quidel until it has trouble settling it off, either with new capital or with free cash flow. So, Quidel's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Quidel sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Quidel to invest in growth at high rates of return. When we think about Quidel's use of debt, we should always consider it together with cash and equity.

Similar Executives

Found 5 records

CEO Age

Albert DaCostaParagon 28
50
Paul GudonisMyomo Inc
69
Gary CrosbyParagon 28
61
Juan QuirosEstablishment Labs Holdings
52
Mark WhiteNexalin Technology
62
QuidelOrtho Corporation focuses on the development and manufacture of diagnostic testing technologies across the continuum of healthcare testing needs. The company was founded in 1979 and is headquartered in San Diego, California. Quidelortho Corp operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 1600 people. Quidel (QDEL) is traded on NASDAQ Exchange in USA. It is located in 9975 Summers Ridge Road, San Diego, CA, United States, 92121 and employs 7,100 people. Quidel is listed under Health Care Equipment & Supplies category by Fama And French industry classification.

Management Performance

Quidel Leadership Team

Elected by the shareholders, the Quidel's board of directors comprises two types of representatives: Quidel inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Quidel. The board's role is to monitor Quidel's management team and ensure that shareholders' interests are well served. Quidel's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Quidel's outside directors are responsible for providing unbiased perspectives on the board's policies.
John Tamerius, Sr. VP of Clinical and Regulatory Affairs
Ruben Argueta, Director Relations
Karen Gibson, Senior Vice President Information Systems and Business Transformation
Thomas Brown, Independent Director
Joseph CPA, Chief Officer
Patrick Klein, Senior Officer
William Ferenczy, Point Leader
Randall Steward, CFO
Robert Bujarski, Senior Vice President - Business Development, General Counsel and Corporate Secretary
Douglas Bryant, CEO and President and Director
Charles Slacik, Director
Michelle JD, General VP
Chockalingam Palaniappan, Chief Officer
Mary Polan, Independent Director
Kenneth Buechler, Independent Director
Michael Abney, Senior Vice President - Distribution
Louise Brandy, Senior Officer
Tamara Ranalli, Molecular Leader
Edward Russell, Senior Vice President - Global Commercial Operations
Phillip Askim, Associate VP
Kenneth Widder, Independent Director
Rodney Dammeyer, Independent Director
Ken Widder, Director
Edward Michael, Director
Kathy Ordonez, Director
Jack Schuler, Independent Director
Werner Kroll, Senior Development
Ratan Borkar, Senior Vice President - International Commercial Operations
Matthew Strobeck, Director
Robert JD, Executive President
Michelle Hodges, General VP
Michael Iskra, Executive Officer

Quidel Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Quidel a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Quidel Investors Sentiment

The influence of Quidel's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Quidel. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Quidel's public news can be used to forecast risks associated with an investment in Quidel. The trend in average sentiment can be used to explain how an investor holding Quidel can time the market purely based on public headlines and social activities around Quidel. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Quidel's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Quidel's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Quidel's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Quidel.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Quidel in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Quidel's short interest history, or implied volatility extrapolated from Quidel options trading.

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Quidel using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
When determining whether Quidel is a strong investment it is important to analyze Quidel's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Quidel's future performance. For an informed investment choice regarding Quidel Stock, refer to the following important reports:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Quidel. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income.
For more information on how to buy Quidel Stock please use our How to buy in Quidel Stock guide.
Note that the Quidel information on this page should be used as a complementary analysis to other Quidel's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.

Complementary Tools for Quidel Stock analysis

When running Quidel's price analysis, check to measure Quidel's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Quidel is operating at the current time. Most of Quidel's value examination focuses on studying past and present price action to predict the probability of Quidel's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Quidel's price. Additionally, you may evaluate how the addition of Quidel to your portfolios can decrease your overall portfolio volatility.
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Is Quidel's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Quidel. If investors know Quidel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Quidel listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.77)
Earnings Share
(0.15)
Revenue Per Share
44.877
Quarterly Revenue Growth
(0.14)
Return On Assets
0.0201
The market value of Quidel is measured differently than its book value, which is the value of Quidel that is recorded on the company's balance sheet. Investors also form their own opinion of Quidel's value that differs from its market value or its book value, called intrinsic value, which is Quidel's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Quidel's market value can be influenced by many factors that don't directly affect Quidel's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Quidel's value and its price as these two are different measures arrived at by different means. Investors typically determine if Quidel is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Quidel's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.